Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3037064rdf:typepubmed:Citationlld:pubmed
pubmed-article:3037064lifeskim:mentionsumls-concept:C0085979lld:lifeskim
pubmed-article:3037064lifeskim:mentionsumls-concept:C0001643lld:lifeskim
pubmed-article:3037064lifeskim:mentionsumls-concept:C0018792lld:lifeskim
pubmed-article:3037064lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:3037064lifeskim:mentionsumls-concept:C0597358lld:lifeskim
pubmed-article:3037064lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:3037064lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:3037064pubmed:issue3lld:pubmed
pubmed-article:3037064pubmed:dateCreated1987-7-30lld:pubmed
pubmed-article:3037064pubmed:abstractTextThe selective beta-2 adrenoceptor agonist procaterol produced positive inotropic and chronotropic responses over a concentration range of 1 nM to 0.1 mM in spontaneously beating right atria and in three of seven electrically driven left atria. The pD2 values (right atria, 7.30; left atria, 7.18) were midway between its known affinities at beta-1 and beta-2 adrenoceptors and are evidence that positive inotropic and chronotropic responses involve a minor beta-2 adrenoceptor component. The pKB values for procaterol against (-)-isoproterenol in the right atria (5.59) and left atria (5.29) were consistent with its affinity for beta-1 adrenoceptors and suggest that these are responsible primarily for positive inotropic and chronotropic responses. Receptor binding studies in right atrial homogenates showed that [125I]cyanopindolol binding was saturable (KD = 36.2 pM, maximal density of binding sites = 49.2 fmol mg-1 protein) and stereoselective with respect to the isomers of propranolol. Competition binding curves for the beta-1 adrenoceptor antagonist CGP 20712A and beta-2 selective antagonist ICI 118,551 against [125I]cyanopindolol binding were resolved into two components using iterative curve fitting techniques. Binding sites with the characteristics of beta-1 and beta-2 adrenoceptors were present in the proportions of approximately 75 to 25%. These studies indicate either that the beta-1 adrenoceptor is coupled more efficiently to the positive inotropic and chronotropic response than the beta-2 adrenoceptor or that a proportion of the beta-2 adrenoceptors subserve other functions.lld:pubmed
pubmed-article:3037064pubmed:languageenglld:pubmed
pubmed-article:3037064pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:citationSubsetIMlld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3037064pubmed:statusMEDLINElld:pubmed
pubmed-article:3037064pubmed:monthJunlld:pubmed
pubmed-article:3037064pubmed:issn0022-3565lld:pubmed
pubmed-article:3037064pubmed:authorpubmed-author:SummersR JRJlld:pubmed
pubmed-article:3037064pubmed:authorpubmed-author:MolenaarPPlld:pubmed
pubmed-article:3037064pubmed:issnTypePrintlld:pubmed
pubmed-article:3037064pubmed:volume241lld:pubmed
pubmed-article:3037064pubmed:ownerNLMlld:pubmed
pubmed-article:3037064pubmed:authorsCompleteYlld:pubmed
pubmed-article:3037064pubmed:pagination1041-7lld:pubmed
pubmed-article:3037064pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:meshHeadingpubmed-meshheading:3037064-...lld:pubmed
pubmed-article:3037064pubmed:year1987lld:pubmed
pubmed-article:3037064pubmed:articleTitleCharacterization of beta-1 and beta-2 adrenoceptors in guinea pig atrium: functional and receptor binding studies.lld:pubmed
pubmed-article:3037064pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3037064pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3037064lld:pubmed